Vera Therapeutics (VERA) Interest & Investment Income (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Interest & Investment Income data on file, last reported at $6.4 million in Q1 2026.

• Quarterly Interest & Investment Income fell 7.98% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.9 million (up 2.11% YoY) and the FY2025 annual result came in at $24.5 million, up 18.18% from the prior year.
• Interest & Investment Income improved to $6.4 million in Q1 2026, from $5.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $6.9 million in Q1 2025 to a low of $26000.0 in Q1 2022.
• A 5-year average of $3.6 million and a median of $4.2 million in 2024 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2022 — Interest & Investment Income surged 14800.0% — and 2025, when it retreated 17.2%.
• Tracing VERA's Interest & Investment Income over 5 years: stood at $894000.0 in 2022, then surged by 119.24% to $2.0 million in 2023, then soared by 239.95% to $6.7 million in 2024, then dropped by 17.2% to $5.5 million in 2025, then climbed by 15.19% to $6.4 million in 2026.
• The last three Interest & Investment Income figures came in at $6.4 million (Q1 2026), $5.5 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.